Company News
Areterna and Biomay Announce Strategic Partnership to Jointly Serve mRNA CDMO Customers in Europe and North America
Collaboration expands Areterna’s reach in Europe and strengthens Biomay’s mRNA CDMO offerings. Gaithersburg, MD and Vienna, Austria (September 18, 2024) — Areterna LLC, a company with a mission to democratize mRNA products by supplying low-cost GMP raw materials,...
GMP Raw Materials Used in Clinical Trials
Synthgene Biotechnology, Areterna's parent company, has been a leading producer of GMP-grade cap analogs, NTPs, and modified NTPs for several years, establishing a strong reputation for quality and reliability in the industry. Our raw materials play a crucial role in...
Synthgene / Areterna now has DMF for CAP5 at FDA
Recently, Synthgene Biotech (hereinafter referred to as "Synthgene"), Areterna’s parent company, received a confirmation letter from the United States Food and Drug Administration (FDA) for one of our core mRNA raw material products – CAP5 – which have been listed on...
Areterna Announces Veterinary mRNA Vaccine Development Service
FOR IMMEDIATE RELEASE Gaithersburg, MD (July 2nd, 2024) — Areterna LLC, a company with a mission to democratize mRNA vaccine by supplying low-cost GMP raw materials, today announced plans to offer veterinary mRNA vaccine development service to its customers in the US...
Areterna LLC, a Synthgene Company, and BIORON GmbH Sign Global Distribution Agreement
FOR IMMEDIATE RELEASE Areterna LLC, a subsidiary of Synthgene Biotech renowned for providing top-tier raw materials and services catering to mRNA and oligonucleotide therapeutics, has signed a global distribution agreement with BIORON GmbH, a premium manufacturer and...
Areterna LLC, a Synthgene Company, and Medsol Corporation Sign Global Distribution Agreement
FOR IMMEDIATE RELEASE Areterna LLC, a subsidiary of Synthgene Biotech, established for the purpose of providing raw materials and services tailored to mRNA and oligonucleotide therapeutics, has entered into a global distribution agreement with Medsol Corporation, a...